X0508 4 2025-07-01 0001671858 ARS Pharmaceuticals, Inc. SPRY 0001951287 Karas Eric C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 false true false false Chief Commercial Officer 1 Common Stock 2025-07-01 4 M 0 15000 1.5 A 25315 D Common Stock 2025-07-01 4 S 0 15000 16.9907 D 10315 D Stock Option (Right to Buy) 1.50 2025-07-01 4 M 0 15000 0 D 2032-05-23 Common Stock 15000 544588 D Includes 2,619 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2025. The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2024. The weighted average sale price for the transaction reported was $16.9907, and the range of prices were between $16.71 and $17.31. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Immediately exercisable. /s/ Kathleen Scott, Attorney-in-Fact 2025-07-03